STOCK TITAN

Park Dental Partners Q3 2026 EPS falls to $0.27

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Park Dental Partners, Inc. (PARK) reported third-quarter 2026 revenue of $64.9 million, up 6.0% from $61.3 million a year earlier, while net income rose 36.1% to $1.7 million. Profitability measures declined: gross margin fell 13.3% to $8.2 million, Adjusted EBITDA fell 6.2% to $5.0 million, and diluted EPS was $0.27 versus $0.72. For the first nine months, revenue was $193.8 million, up 5.8%, while net income was $2.7 million, down 50.6%, and Adjusted EBITDA was $17.1 million, down 6.5%.

After completing the Village Family DSO acquisition, the company incorporated the acquired practice group's expected contribution from closing through year-end into its 2026 outlook. It projects revenue of $262.0 million to $265.0 million and Adjusted EBITDA of $21.2 million to $22.2 million, with an Adjusted EBITDA margin of 8.1% to 8.4%. Management said the outlook also reflects increased clinical-capacity investment, including hiring and onboarding additional hygienists in the second half, and the impact of the third-quarter cybersecurity event. The acquisition extends its affiliated practice network into a fourth state.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 6 points

How the balance works

Positive

  • Moderate pointThird-quarter revenue increased 6.0% to $64.9 million.
  • Moderate pointThird-quarter net income increased 36.1% to $1.7 million.

Negative

  • Moderate pointThird-quarter gross margin fell 13.3% to $8.2 million.
  • Moderate pointThird-quarter Adjusted EBITDA fell 6.2% to $5.0 million.
  • Moderate pointThird-quarter diluted EPS was $0.27, versus $0.72.
  • Moderate pointNine-month net income fell 50.6% to $2.7 million.
  • Moderate pointNine-month gross margin fell 22.8% to $24.1 million.
  • Moderate pointNine-month Adjusted EBITDA fell 6.5% to $17.1 million.

Filing Explained

The 2026 Adjusted EBITDA outlook is a non-GAAP forecast; the company provides neither a comparable GAAP figure nor a reconciliation, saying unpredictable noncash, nonrecurring and other items make that impracticable without unreasonable effort.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Third-quarter revenue $64.9 million Three months ended September 30, 2026; up 6.0% from $61.3 million
Third-quarter gross margin $8.2 million Three months ended September 30, 2026; down 13.3% from $9.4 million
Third-quarter net income $1.7 million Three months ended September 30, 2026; up 36.1% from $1.3 million
Diluted EPS $0.27 Three months ended September 30, 2026; compared with $0.72 in 2025
Adjusted EBITDA $5.0 million Three months ended September 30, 2026; down 6.2% from $5.3 million
2026 revenue outlook $262.0 million to $265.0 million Year ending December 31, 2026
2026 Adjusted EBITDA outlook $21.2 million to $22.2 million Year ending December 31, 2026
2026 Adjusted EBITDA margin outlook 8.1% to 8.4% Year ending December 31, 2026
Adjusted EBITDA financial
"Adjusted EBITDA (b)"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Same Practice Revenue Growth financial
"Same Practice Revenue Growth"
Same practice revenue growth measures how much revenue has risen or fallen at medical or professional practices that were operating in both the current and prior reporting periods, excluding income from newly acquired or newly opened locations. Think of it like comparing sales at the same set of stores instead of counting results from fresh storefronts; it tells investors whether existing operations are gaining patients, charging more, or improving efficiency, and thus reveals the business’s organic performance apart from expansion.
Adjusted Gross Margin financial
"Adjusted Gross Margin (a)"
Adjusted gross margin is a measure of how much profit a company makes from its sales after accounting for certain expenses or one-time costs, but before deducting other operating expenses. It helps investors see the company's core profitability more clearly by removing factors that might distort the usual profit picture, similar to a runner measuring their speed without considering obstacles or weather. This metric provides a clearer view of the company's ongoing financial health.
non-GAAP financial measures financial
"Non-GAAP Financial Measures"
Non-GAAP financial measures are numbers companies use to show their financial performance that exclude certain expenses or income. They help investors see how the company might perform without one-time costs or other unusual items, giving a different perspective from official reports. However, since they can be adjusted, they don’t always tell the full story and should be looked at alongside standard financial figures.
long-term administrative resource agreements technical
"under long-term administrative resource agreements with us"
Revenue $64.9 million +6.0% from $61.3 million
Gross margin $8.2 million -13.3% from $9.4 million
Net income $1.7 million +36.1% from $1.3 million
Diluted EPS $0.27 -$0.45 from $0.72
Adjusted EBITDA $5.0 million -6.2% from $5.3 million
Guidance

2026 outlook: revenue of $262.0 million to $265.0 million; Adjusted EBITDA of $21.2 million to $22.2 million; Adjusted EBITDA margin of 8.1% to 8.4%.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were Park Dental Partners' (PARK) third-quarter 2026 revenue and net income?

Park Dental Partners reported third-quarter revenue of $64.9 million, up 6.0% from $61.3 million in the prior-year quarter. Net income was $1.7 million, up 36.1% from $1.3 million.

What is Park Dental Partners' (PARK) 2026 financial outlook?

The company projected 2026 revenue of $262.0 million to $265.0 million and Adjusted EBITDA of $21.2 million to $22.2 million. Its outlook also included an Adjusted EBITDA margin of 8.1% to 8.4%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0002069604false00020696042026-11-122026-11-12

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 12, 2026

Park Dental Partners, Inc.

(Exact name of registrant as specified in its charter)

​

​

​

​

​

​

Minnesota

  ​ ​ ​

001-42967

  ​ ​ ​

93-2020683

(State or other jurisdiction of
incorporation or organization)

​

(Commission File Number)

​

(I.R.S. Employer
Identification Number)

​

2200 County Road C West, Suite 2210

Roseville, Minnesota 55113

(Address of Principal Executive Offices) (Zip Code)

​

(651) 633-0500

(Registrant's Telephone Number, Including Area Code)

​

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

​

​

​

​

​

​

Title of each class

  ​ ​ ​

Trading Symbol

  ​ ​ ​

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

​

PARK

​

The Nasdaq Capital Market

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

​

​

Item 2.02 Results of Operations and Financial Condition.

On November 12, 2026, Park Dental Partners, Inc. (the “Company”) issued a press release on the Company’s website announcing its third quarter 2026 financial results for the reporting period ended September 30, 2026. On November 13, 2026, the Company will host its quarterly earnings conference call, which will be accessible to the public.

A copy of the Company’s press release is furnished as Exhibit 99.1 and is attached to this Current Report on Form 8-K. The information in this Item 2.02 and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filings under the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

​

​

​

Exhibit No.

  ​ ​ ​

Exhibit

99.1

​

Press Release dated November 12, 2026 of Park Dental Partners, Inc.

104

​

Cover Page Interactive Data File (formatted as Inline XBRL)

​

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 12, 2026

​

​

​

​

PARK DENTAL PARTNERS, INC.

​

​

​

​

By:

/s/ Christopher J. Bernander

​

Name:

Christopher J. Bernander

​

Title:

Chief Financial Officer

​

Exhibit 99.1

Park Dental Partners Announces Third Quarter 2026 Results

 
FOR IMMEDIATE RELEASE

​

Minneapolis, Minn. — November 12, 2026 — Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its third quarter financial results for 2026.  Summary financial results are listed below and in the accompanying supplemental financial tables.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

(Unaudited, in millions, except per share data,

​

Three Months Ended September 30, 

​

​

Nine Months Ended September 30, 

​

and Doctor counts)

  ​ ​ ​

2026

  ​ ​ ​

​

2025

  ​ ​ ​

​

Change

  ​ ​ ​

​

2026

  ​ ​ ​

​

2025

  ​ ​ ​

​

Change

​

Revenue

 

$

64.9

 

​

$

61.3

 

​

​

6.0

%

​

$

193.8

 

​

$

183.3

 

​

​

5.8

%

Gross Margin

 

$

8.2

 

​

$

9.4

 

​

​

(13.3)

%

​

$

24.1

 

​

$

31.2

 

​

​

(22.8)

%

Gross Margin percentage

​

​

12.6

%  

​

​

15.4

%  

​

​

(280)

bps

​

​

12.4

%  

​

​

17.0

%  

​

​

(460)

bps

Net Income

​

$

1.7

 

​

$

1.3

 

​

​

36.1

%

​

$

2.7

 

​

$

5.4

 

​

​

(50.6)

%

Diluted EPS

​

$

0.27

 

​

$

0.72

 

​

$

(0.45)

​

​

$

0.43

 

​

$

3.06

 

​

$

(2.63)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Adjusted Gross Margin(a)

 

$

12.1

 

​

$

11.9

 

​

​

1.6

%

​

$

39.0

 

​

$

37.9

 

​

​

2.9

%

Adjusted Gross Margin Percentage(a)

​

​

18.6

%  

​

​

19.4

%  

​

​

(80)

bps

​

​

20.1

%  

​

​

20.7

%  

​

​

(60)

bps

Adjusted EBITDA(b)

 

$

5.0

 

​

$

5.3

 

​

​

(6.2)

%

​

$

17.1

 

​

$

18.3

 

​

​

(6.5)

%

Adjusted EBITDA margin(b)

​

​

7.7

%  

​

​

8.7

%  

​

​

(100)

bps

​

​

8.8

%  

​

​

10.0

%  

​

​

(120)

bps

Adjusted Diluted EPS(c)

 

$

0.57

 

​

$

1.19

 

​

$

(0.62)

​

​

$

1.68

 

​

$

4.21

 

​

$

(2.53)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Same Practice Revenue Growth

​

​

3.2

%  

​

​

9.9

%  

​

​

(670)

bps

​

​

3.0

%  

​

​

5.8

%  

​

​

(280)

bps

Practicing Affiliated Doctors

​

​

225

​

​

​

218

 

​

​

3.2

%

​

​

​

​

​

​

​

 

​

​

​

​

​

(a)

See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin below

(b)

See Non GAAP Reconciliation of Net Income to Adjusted EBITDA below

(c)

See Non GAAP Reconciliation of Earnings Per Share to Adjusted Earnings Per Share below

​

Executive Commentary – Pete Swenson, Chief Executive Officer and Chair of the Board of Directors

"Third-quarter revenue increased 6%, supported by same-practice growth, an expanding affiliated doctor base and contributions from recently acquired practices. We have made meaningful progress adding clinical capacity and strengthening our platform, and our focus now is converting that capacity and revenue growth into improved productivity and stronger earnings performance.

​

The completion of the Village Family transaction represents an important step in our growth strategy and extends our affiliated practice network into a fourth state. We remain focused on disciplined integration, supporting our affiliated practices and executing against the opportunities already within our business.”

​

Financial Results

●Revenue increased 6.0% to $64.9 million for the third quarter of 2026, compared to $61.3 million in the prior-year period. For the first nine months of 2026, revenue increased 5.8% to $193.8 million, compared to $183.3 million in the prior-year period. The increases were primarily driven by reimbursement trends, acquisitions completed since the comparable prior-year periods, and growth in clinical hours. Revenue from acquisitions in the past 12 months contributed approximately $1.2 million in the quarter and $3.7 million year-to-date.
●Gross margin was $8.2 million for the third quarter of 2026, compared to $9.4 million in the prior-year period. For the first nine months of 2026, gross profit was $24.1 million, compared to $31.2 million in the prior-year period. Gross profit was impacted by higher salaries and benefits expense, including doctor share-based compensation associated with the Company's public company transition.
●Net income was $1.7 million, or $0.27 per diluted share, for the third quarter of 2026, compared to $1.3 million, or $0.72 per diluted share, in the third quarter of 2025. For the first nine months of 2026, net income was $2.7 million, or $0.43 per diluted share, compared to $5.4 million, or $3.06 per diluted share, in the prior-year period.
●Adjusted EBITDA was $5.0 million for the third quarter of 2026, compared to $5.3 million in the prior-year period. For the first nine months of 2026, Adjusted EBITDA was $17.1 million, compared to $18.3 million in the prior-year period.
●Adjusted diluted earnings per share was $0.57 for the third quarter of 2026, compared to $1.19 in the prior-year period. For the first nine months of 2026, adjusted diluted earnings per share was $1.68, compared to $4.21 in the prior-year period.

​

1


Affiliated Practice Updates

●As of September 30, 2026, we supported 88 affiliated practices and 225 affiliated doctors.
●Third quarter patient retention rate was 90.2%.
●Patient visits increased to 180,955 across our affiliated dental practices.
●During the third quarter our affiliated dental practices completed one general practice acquisition in Arizona, as previously announced on September 23, 2026. The acquired practice’s impact on revenues and net earnings was not material for the quarter.
●As announced earlier this week, we completed the acquisition of Village Family DSO on November 6, 2026. The Village Family DSO is currently affiliated with Village Family Dental practices, a multi-specialty dental group based in Fayetteville, North Carolina. Integration activities commenced immediately following completion of the acquisition and Village Family financial performance will be included in our financial results beginning in the fourth quarter of 2026.

​

Balance Sheet, Liquidity, and Cash Flow

●Cash and cash equivalents were $23.2 million as of September 30, 2026.
●Total debt outstanding was approximately $10.6 million as of September 30, 2026, and our $15 million line of credit was undrawn at quarter end.
●Total shares outstanding were 5.1 million shares as of the end of the quarter.
●We generated $12.0 million in operating cash flow in the first nine months of 2026, a decrease of $4.8 million compared to the prior year that was driven by timing of working capital.
●Year-to-date capital investments were $7.6 million.

​

Full-Year 2026 Outlook

Following the completion of the Village Family DSO acquisition, we have incorporated the expected contribution from Village Family DSO for the remainder of 2026 into our full-year outlook. The outlook reflects Village Family DSO’s expected contribution from the closing date through year-end, as well as our current expectations for existing operations.

​

The updated outlook also reflects increased investment in clinical capacity, including the hiring and onboarding of additional hygienists during the second half of the year, as well as the impact of the cybersecurity event experienced during the third quarter. We believe the additional investments in clinical capacity position our affiliated practices to serve additional patient demand and support future growth.

​

​

​

​

​

​

​

​

​

​

​

​

​

 

Year Ending

 

Year Ended

​

Percent

​

​

 

December 31, 2026

 

December 31, 2025

​

Change

​

($ in millions)

  ​ ​ ​

(Outlook)

  ​ ​ ​

(Actual)

  ​ ​ ​

(At Midpoint)

​

Revenue

​

​

$262.0 – $265.0

​

$

244.5

 

​

5.5

%

Adjusted EBITDA

​

​

$21.2 – $22.2

​

$

22.0

 

​

—

​

Adjusted EBITDA margin

​

 

8.1% - 8.4%

​

 

9.0

%  

​

  ​

​

​

The outlook assumes continued patient demand across general and specialty services, stable reimbursement trends, ongoing recruitment and retention initiatives, and contributions from recently affiliated practices. We continue to monitor patient demand, industry and professional staffing trends that could impact our outlook.

​

We expect to provide our full-year 2027 outlook in connection with the reporting of our fourth-quarter and full-year 2026 results.

​

Conference Call

​

As previously announced, the Company will host a conference call to discuss these results tomorrow morning, Friday, November 13, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

​

A live webcast of the call will be accessible by registering using the link below or through the Investor Relations section of the Company’s website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited time following the call.

​

​

2


About Park Dental Partners, Inc.

Park Dental Partners, Inc., and its subsidiaries (NASDAQ:PARK) is a dental resource organization that has put patients first since the establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. As of September 30, 2026, the Company has supported 225 affiliated doctors across 88 practice locations in three states. The Company’s clinical support team consists of over 1,000 hygienists, dental assistants, and patient care coordinators that support affiliated doctors in operating their practices. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today.

Park Dental Partners is based in Roseville, Minnesota. For more information, please visit parkdentalpartners.com. Information contained on, or that can be accessed through, our website is not incorporated by reference into, and should not be considered a part of, this press release.

​

Basis of Consolidation

In accordance with generally accepted accounting principles in the United States, we consolidate the net assets and results of operations of the affiliated dental practices operating under long-term administrative resource agreements with us. As a result, references to our revenues, our expenses and similar items relating to our results of operations and net assets includes the revenues, expenses and similar items of our affiliated dental practices and all transactions between the affiliated dental practices and us, such as the service fees we charge, are eliminated in consolidation.

​

Forward Looking Statements

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to the Company’s financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include those preceded by, followed by or that include the words “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “will,” or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by such forward-looking statements because of, among other things, potential risks and uncertainties, such as:

​

●Regulatory and compliance risk, including state dental corporate practice of dentistry and fee-splitting restrictions, HIPAA and other privacy/cybersecurity obligations, and evolving healthcare and labor regulations;
●Reimbursement risk, including risks related to payer mix, reimbursement rates, audit/recoupment activity, enrollment and collections timing, and dependence on significant third-party payors;
●Our ability to identify, acquire, integrate and effectively support affiliated practices and to execute de novo expansion, and the risk of undiscovered liabilities in acquisitions;
●Dependence on affiliated dental practices and their clinical performance; our ability to attract, hire and retain dentists, specialists and hygienists; and risks related to ownership transitions of affiliated entities;
●Competition for patients and clinicians in our markets and the impact on patient volumes and staffing;
●Macroeconomic conditions, inflation and interest rates, and our geographic concentration, particularly in the markets in which we operate.

​

A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether because of new information, future events or otherwise.

​

Non-GAAP Financial Measures

This news release and the related conference call include presentation of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature. Management believes that the Non-GAAP measures provide useful information to investors regarding the Company’s results of operations and financial condition because they permit a more meaningful comparison and understanding of Park Dental Partners, Inc’s operating performance for the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends and to gain an understanding of the comparative operating performance of the Company.

​

Please note that the Company has not provided the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, for the Adjusted EBITDA forward-looking guidance for 2026 included in this press release in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. Providing the most directly comparable GAAP financial measure, or a quantitative reconciliation thereto, cannot be done without unreasonable effort due to the inherent uncertainty and difficulty in predicting certain non-cash, material and/or non-recurring expenses or benefits; legal settlements or other matters; and

3


certain tax positions. The variability of these items could have an unpredictable, and potentially significant, impact on our future GAAP financial results.

​

See Supplemental non-GAAP financial tables below for a reconciliation of adjusted non-GAAP financial measures to GAAP.
​

Company Contact Information

Investor Contact:

​

Park Dental Partners Investor Relations Team

763-233-3377

ir@parkdentalpartners.com

​

Media Contact:

​

Park Dental Partners Media Relations Team

651-633-0500

marketing@parkdentalpartners.com

​

​

4


Supplemental Financial Tables

​

​

PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

(in thousands, except share and per share amounts)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

  ​ ​ ​

Nine Months Ended

​

​

September 30, 

​

September 30, 

​

​

​

2026

​

​

2025

​

2026

  ​ ​ ​

2025

REVENUE

  ​ ​ ​

$

64,926

  ​ ​ ​

$

61,251

​

$

193,833

​

$

183,286

COST OF SERVICES

 

​

​

 

​

​

​

 

​

​

 

​

Salaries and benefits

 

 

41,896

 

 

37,785

​

 

125,905

​

 

110,518

Dental supplies and Laboratory fees

 

 

4,474

 

 

4,258

​

 

13,256

​

 

12,834

Office occupancy

 

​

4,393

 

​

4,043

​

 

13,053

​

 

12,133

Other practice expenses

​

​

3,998

​

​

3,726

​

 

11,668

​

 

10,741

Depreciation

 

 

1,983

 

 

2,002

​

 

5,874

​

 

5,861

TOTAL COST OF SERVICES

 

 

56,743

 

 

51,814

​

 

169,756

​

 

152,087

GROSS MARGIN

 

 

8,183

 

 

9,437

​

 

24,077

​

 

31,199

General and administrative expenses

 

 

7,863

 

 

7,265

​

 

23,539

​

 

21,573

Depreciation and amortization

 

 

434

 

 

389

​

 

1,276

​

 

1,141

OPERATING INCOME (LOSS)

 

 

(114)

 

 

1,783

​

 

(738)

​

 

8,485

INTEREST EXPENSE - NET

 

 

(89)

 

 

(259)

​

 

(347)

​

 

(930)

INCOME (LOSS) BEFORE TAXES

 

​

(203)

 

​

1,524

​

 

(1,085)

​

 

7,555

PROVISION/(BENEFIT) FOR INCOME TAXES

 

 

(1,905)

 

 

274

​

 

(3,746)

​

 

2,168

NET INCOME

 

$

1,702

 

$

1,251

​

$

2,661

​

$

5,387

Earnings per share:

 

 

​

​

 

​

​

 

​

​

 

​

Basic

 

$

0.35

 

$

0.72

​

$

0.58

​

$

3.06

Diluted

 

$

0.27

 

$

0.72

​

$

0.43

​

$

3.06

Basic weighted-average number of common shares outstanding

 

 

4,838,267

 

 

1,729,179

​

 

4,599,514

​

 

1,761,510

Diluted weighted-average number of common shares outstanding

 

 

6,360,881

 

 

1,729,179

​

 

6,179,442

​

 

1,761,510

​

​

​

5


PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET (unaudited)

(in thousands)

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

At September 30, 

  ​ ​ ​

At December 31,

​

​

2026

​

2025

ASSETS

 

​

  ​

 

​

  ​

Cash and cash equivalents

 

$

23,226

 

$

25,185

Accounts receivable – net of allowance

​

​

8,916

​

​

6,991

Other current assets

​

 

8,385

​

 

5,726

Total current assets

​

 

40,527

​

 

37,902

OTHER ASSETS:

​

 

​

​

 

​

Property and equipment and lease assets

​

 

75,521

​

 

73,828

Goodwill and Intangible assets, nets

​

​

32,527

​

​

28,360

Other assets

​

 

41,212

​

 

38,093

Total other assets

​

 

149,260

​

 

140,281

TOTAL ASSETS

​

$

189,787

​

$

178,183

LIABILITIES AND DEFICIT

​

 

​

​

 

​

Accounts payable and other accrued liabilities

​

$

5,710

​

$

6,291

Payroll, benefits and short term deferred compensation

​

 

16,927

​

 

16,716

Current portion of debt and lease liabilities

​

 

8,945

​

 

8,606

Deferred Revenue and other current liabilities

​

​

5,276

​

​

4,120

Total current liabilities

​

​

36,858

​

​

35,733

LONG-TERM LIABILITIES:

​

​

  ​

​

 

  ​

Deferred compensation

​

 

68,147

​

 

68,417

Long-term debt and lease liabilities

​

​

50,078

​

​

51,744

Other long-term liabilities

​

 

607

​

 

486

Total long-term liabilities

​

 

118,832

​

 

120,647

TOTAL LIABILITIES

​

$

155,690

​

$

156,380

Total shareholders’ equity

​

$

34,097

​

$

21,803

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

​

$

189,787

​

$

178,183

​

​

​

6


PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

(in thousands)

​

​

​

​

​

​

​

​

​

​

​

Nine Months Ended

​

​

September 30, 

​

 

2026

  ​ ​ ​

2025

CASH FLOWS FROM OPERATING ACTIVITIES:

​

​

  ​

 

​

  ​

Net income

​

$

2,661

​

$

5,387

Adjustments to reconcile net income to net cash flows from operating activities:

​

 

​

​

 

​

Depreciation and amortization

​

 

7,150

​

 

7,002

Deferred income taxes

​

 

(1,524)

​

 

—

Change in cash surrender value of life insurance

​

 

(1,083)

​

 

(1,589)

Noncash lease and loss on disposal of equipment

​

 

46

​

 

24

Share based compensation

​

 

9,137

​

 

—

Interest received on notes to related parties

​

​

4

​

​

—

Changes in operating assets and liabilities

​

 

(4,425)

​

 

5,961

Net cash flows from operating activities

​

 

11,966

​

 

16,785

NET CASH FLOWS USED IN INVESTING ACTIVITIES:

​

 

​

​

 

​

Purchases of property and equipment

​

$

(7,571)

​

$

(6,005)

Life insurance premiums paid

​

 

(491)

​

 

(1,287)

Payments for purchases of dental practices

​

 

(4,090)

​

 

(804)

Issuance of notes to related parties

​

 

(600)

​

 

—

Collection of notes to related parties

​

​

173

​

 

—

Net cash flows used in investing activities

​

 

(12,579)

​

 

(8,096)

CASH FLOWS USED IN FINANCING ACTIVITIES:

​

 

​

​

 

​

Dental practice purchase payments on deferred notes

​

$

(289)

​

$

(568)

Net change in checks issued in excess of cash balances

​

 

(96)

​

 

(243)

Net payments on debt and capital leases

​

 

(1,457)

​

 

(1,470)

Cash paid for Share Repurchase

​

 

—

​

 

(704)

Issuance of common shares

​

​

496

​

​

—

Net cash flows used in financing activities

​

 

(1,346)

​

 

(2,985)

NET CHANGE IN CASH AND CASH EQUIVALENTS

​

 

(1,959)

​

 

5,704

CASH AND CASH EQUIVALENTS – Beginning of period

​

 

25,185

​

 

2,672

CASH AND CASH EQUIVALENTS - End of period

​

$

23,226

​

$

8,376

​

​

​

7


PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES
RECONCILIATION OF GROSS MARGIN TO ADJUSTED GROSS MARGIN (unaudited)

(in thousands)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the three months ended

​

For the nine months ended

​

​

September 30, 

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Gross Margin

 

$

8,183

​

12.6%

​

$

9,437

​

15.4%

 

$

24,077

​

12.4%

​

$

31,199

​

17.0%

Addback:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Share based compensation

​

 

1,806

​

2.8%

​

 

-

​

0.0%

​

 

8,269

​

4.3%

​

 

-

​

0.0%

Restructuring(1)

​

 

32

​

0.0%

​

 

-

​

0.0%

​

 

69

​

0.0%

​

 

109

​

0.1%

Deferred compensation(2)

​

 

72

​

0.1%

​

 

444

​

0.7%

​

 

664

​

0.3%

​

 

698

​

0.4%

Depreciation

​

 

1,983

​

3.1%

​

 

2,002

​

3.3%

​

 

5,874

​

3.0%

​

 

5,861

​

3.2%

Adjusted Gross Margin

​

$

12,076

​

​

​

$

11,883

​

​

​

$

38,953

​

​

​

$

37,867

​

​

Adjusted Gross Margin Percentage

​

​

​

​

18.6%

​

​

​

​

19.4%

​

​

​

​

20.1%

​

​

​

​

20.7%

​

(1)Restructuring costs primarily consist of gains and losses from the disposal of equipment.
(2)Deferred compensation costs primarily consist of expenses incurred with the Company's active and inactive deferred compensation arrangements.

​

​

8


PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (unaudited)

(in thousands)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the three months ended

​

For the nine months ended

​

​

September 30, 

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Net Income

 

$

1,702

​

2.6%

​

$

1,251

​

2.0%

 

$

2,661

​

1.4%

​

$

5,387

​

2.9%

Addback/(Deduct):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Provision/(Benefit) for income taxes

​

 

(1,905)

​

(2.9%)

​

 

274

​

0.4%

​

 

(3,746)

​

(1.9%)

​

 

2,168

​

1.2%

Interest expense, net

​

 

89

​

0.1%

​

 

259

​

0.4%

​

 

347

​

0.2%

​

 

930

​

0.5%

Depreciation and amortization

​

 

2,417

​

3.7%

​

 

2,391

​

3.9%

​

 

7,150

​

3.7%

​

 

7,002

​

3.8%

EBITDA

​

$

2,303

​

3.5%

​

$

4,175

​

6.8%

​

$

6,412

​

3.3%

​

$

15,487

​

8.4%

Adjustments:

​

 

​

​

​

​

 

​

​

​

​

 

​

​

​

​

 

​

​

​

Share based compensation

​

​

2,078

​

3.2%

​

​

-

​

0.0%

​

​

9,137

​

4.7%

​

​

-

​

0.0%

Acquisition and integration costs(1) (5)

​

​

484

​

0.7%

​

​

-

​

0.0%

​

​

831

​

0.4%

​

​

-

​

0.0%

Initial public offering costs(2) (5)

​

​

-

​

0.0%

​

​

680

​

1.1%

​

​

21

​

0.0%

​

​

1,947

​

1.1%

Restructuring(3) (5)

​

​

32

​

0.0%

​

​

-

​

0.0%

​

​

69

​

0.0%

​

​

184

​

0.1%

Deferred compensation(4)

​

​

72

​

0.1%

​

​

444

​

0.7%

​

​

664

​

0.3%

​

​

698

​

0.4%

Adjusted EBITDA

​

$

4,969

​

​

​

$

5,299

​

​

​

$

17,134

​

​

​

$

18,316

​

​

Adjusted EBITDA Percentage

​

​

​

​

7.7%

​

​

​

​

8.7%

​

​

​

​

8.8%

​

​

​

​

10.0%

​

(1)Acquisition integration costs primarily consist of expenses related to acquisition related legal costs and integration related costs.
(2)Initial public offering costs primarily consist of expenses incurred in connection with the Company’s initial public offering.
(3)Restructuring costs primarily consist of gains and losses from the disposal of equipment.
(4)Deferred compensation costs primarily consist of expenses incurred with the Company's active and inactive deferred compensation arrangements.
(5)Prior-period amounts have been recast to conform to the current-period presentation. The recast reflects the reclassification of amounts previously reported as restructuring costs into initial public offering costs, acquisition and integration costs, and restructuring costs and had no impact on total non-GAAP adjustments.

​

9


PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

RECONCILIATION OF EARNINGS PER SHARE TO ADJUSTED EARNINGS PER SHARE (unaudited)

(in thousands, except share and per share amounts)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the three months ended

​

​

​

For the nine months ended

​

​

September 30, 

​

​

​

September 30, 

​

​

2026

  ​ ​ ​

​

  ​ ​ ​

2025

  ​ ​ ​

​

​

2026

  ​ ​ ​

​

  ​ ​ ​

2025

EARNINGS ATTRIBUTABLE TO COMMON SHAREHOLDERS:

​

$

1,702

​

​

​

$

1,251

​

​

​

$

2,661

​

​

​

$

5,387

Adjustments:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Share based compensation

​

​

2,078

​

​

​

​

-

​

​

​

​

9,137

​

​

​

​

-

Acquisition and integration costs(1) (6)

​

​

484

​

​

​

​

-

​

​

​

​

831

​

​

​

​

-

Initial public offering costs(2) (6)

​

​

-

​

​

​

​

680

​

​

​

​

21

​

​

​

​

1,947

Restructuring(3) (6)

​

​

32

​

​

​

​

-

​

​

​

​

69

​

​

​

​

184

Deferred compensation(4)

​

​

72

​

​

​

​

444

​

​

​

​

664

​

​

​

​

698

Income tax effect of the Adjustments(5)

​

​

(746)

​

​

​

​

(315)

​

​

​

​

(3,002)

​

​

​

​

(792)

ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS

​

$

3,622

​

​

​

$

2,060

​

​

​

$

10,381

​

​

​

$

7,424

​

​

 

​

​

​

​

 

​

​

​

​

 

​

​

​

​

 

​

Adjusted Weighted Average Diluted Shares - Reconciliation

​

 

​

​

​

​

 

​

​

​

​

 

​

​

​

​

 

​

WEIGHTED-AVERAGE SHARES USED IN COMPUTING GAAP NET EARNINGS PER SHARE, DILUTED

​

​

6,360,881

​

​

​

​

1,729,179

​

​

​

​

6,179,442

​

​

​

​

1,761,510

ADJUSTED WEIGHTED AVERAGE DILUTED SHARES USED IN COMPUTING ADJUSTED EARNINGS PER SHARE, DILUTED

​

​

6,360,881

​

​

​

​

1,729,179

​

​

​

​

6,179,442

​

​

​

​

1,761,510

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

ADJUSTED DILUTED EARNINGS PER SHARE:

​

$

0.57

​

​

​

$

1.19

​

​

​

$

1.68

​

​

​

$

4.21

​

(1)Acquisition integration costs primarily consist of expenses related to acquisition related legal costs and integration related costs.
(2)Initial public offering costs primarily consist of expenses incurred in connection with the Company’s initial public offering.
(3)Restructuring costs primarily consist of gains and losses from the disposal of equipment.
(4)Deferred compensation costs primarily consist of expenses incurred with the Company's active and inactive deferred compensation arrangements.
(5)Income tax effect is based on an estimated long-term annual effective tax rate of 28% tax rate for the three and nine months ended September 30, 2026 and September 30, 2025. The Company's estimated long-term annual effective tax rate excludes certain non-cash items such as share based compensation arrangements, and is used in order to provide consistency across periods.
(6)Prior-period amounts have been recast to conform to the current-period presentation. The recast reflects the reclassification of amounts previously reported as restructuring costs into initial public offering costs, acquisition and integration costs, and restructuring costs and had no impact on total non-GAAP adjustments.

​

​

​

10


PARK DENTAL PARTNERS, INC. AND SUBSIDIARIES

CONSOLIDATED OPERATING METRICS (unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Three Months Ended

​

Nine Months Ended

​

​

September 30, 

​

September 30, 

​

​

2026

  ​ ​ ​

2025

 

2026

  ​ ​ ​

2025

​

​

​

​

​

​

​

​

​

​

​

​

​

Patient Visits(1)

 

​

180,955

​

​

179,111

​

​

545,051

​

​

540,240

Same Practice Revenue Growth(2)

 

​

3.2%

​

​

9.9%

​

​

3.0%

​

​

5.8%

Patient Retention Rate(3)

 

​

90.2%

​

​

89.8%

​

​

90.2%

​

​

89.8%

Doctor Count(4)

 

​

225

​

​

218

​

​

​

​

​

​

​

​

(1)A patient visit is counted when service is provided to a patient at one of our affiliated dental general dentistry practices. Measuring the year-over-year change in patient visits helps us to evaluate how the affiliated dental practices are performing. It also helps with evaluating demand for services which influences decision-making relating to matters such as appropriate staffing levels and recruiting needs. In addition, it influences decision-making processes relating to our marketing, sales and advertising strategies and helps us with evaluating the effectiveness of those strategies. Further, with respect to continuing care patient count, it allows us to evaluate the ability of affiliated dentists to encourage patients to complete their diagnosed dental treatment plans.
(2)Same practice revenues represent total revenues for same dental practice locations that have been operating for at least 13 full months prior to the end of a given reporting period and which have not been closed, or sold during such period. Measuring the year-over-year change in same practice revenues allows us to evaluate how affiliated dental practices are performing. We believe various factors affect comparable practice revenues, including patient demand for dental services, economic trends, dentist and hygienist staffing levels, availability of dentists and hygienists, pricing, competition, visibility and accessibility of the dental practices, quality of the tenants surrounding the dental practices, clinical hours and the level of patient service provided inside and outside of the dental practices.
(3)Patient retention rate is calculated by counting patients that remain active at the beginning and end of a twelve-month period. Active patients are defined as general dentistry patients having been seen by our affiliated dental practices within the past 36 months, or last 18 months for patients under the age of 18. Patients who have not been seen by our affiliated dental practices within these time periods are removed from our active patient lists. This methodology is aligned with ADA clinical procedure codes, and is consistent with treatment protocols for new patients, before being considered an active patient again. Measuring the year-over-year and quarter-over-quarter change in patient retention allows us to evaluate the recurring nature of patient visits at the dental practices and affiliated dentists which influences decision-making around matters such as appropriate levels of staffing, recruiting, advertising and facility expansion opportunities.
(4)Dentists operating in one of our affiliated dental practices are included in this calculation, which includes both full and part-time dentists. Measuring the year-over-year and quarter-over- quarter change in dentist count allows us to evaluate the production capacity of affiliated dental practices. It also influences decision-making relating to matters such as appropriate staffing levels and recruiting needs.

11


Filing Exhibits & Attachments

5 documents

Keep reading